Mechanism of Action
hormone, somatostatin. It is an even more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Like somatostatin, it also suppresses LH response to GnRH, decreases splanchnic blood flow, and inhibits release of serotonin, gastrin, vasoactive intestinal peptide, secretin,…
Indications (1)
Clinical Trials (5)
Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas
Effects of Sandostatin LAR® in Acromegaly
Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either With GH-receptor Antagonist or Dopamine-agonist in Acromegalic Patients
Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly